Tuhura Biosciences Inc (HURA) Stock Price, Quote & News

Company Profile

TuHURA Biosciences, Inc., a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. It is also preparing to initiate a single randomized placebo-controlled which is in Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda; and Delta receptor technology to dev...

Industry: Biotechnology

Sector: Healthcare

Phone: 813 875 6600

Website: www.tuhurabio.com

Address:

10500 University Center Drive, Suite 110, Tampa, United States

Gotsomescrewsmissing Aug. 18 at 6:57 PM

$HURA HURA: All proposals passed, including director elections and share issuance, with no stockholder questions — TradingView News https://share.google/9lBKx34WrDdcK5GiS

0 · Reply

TuHURA_IR Aug. 17 at 4:46 PM

$HURA Antibody-drug conjugates have become one of the fastest-growing areas in oncology, but not every platform approaches them the same way. Rather than delivering a cytotoxic payload directly to tumor cells, our ADC platform is designed to target the immune-suppressive cells that limit the effectiveness of immunotherapy. Watch this segment for a closer look at the science behind our approach. https://youtu.be/ylYDnzmylG8

0 · Reply

PastaSlobCFA Aug. 17 at 5:09 AM

$HURA $3.00 this week easily!!!

2 · Reply

toesinthesand Aug. 16 at 3:38 AM

$HURA going to 10

1 · Reply

steven1x Aug. 14 at 1:30 PM

$HURA https://ir.tuhurabio.com/news-events/press-releases/detail/48/tuhura-biosciences-reports-second-quarter-2026-financial-results-and-provides-a-corporate-update

0 · Reply

TuHURA_IR Aug. 14 at 1:12 PM

$HURA As our pipeline expands, investors increasingly ask how the different programs fit together. One mission drives everything in our pipeline: overcoming resistance to cancer immunotherapy. IFx-2.0, TBS-2025, and our ADC platform each address a different aspect of that challenge, with milestones expected across the coming year. Hear Dr. James Bianco recap how the programs fit together and where they are headed. https://youtu.be/b1UIcmk5cDg

0 · Reply

Danielord Aug. 14 at 12:09 AM

$HURA 1,5 next week

0 · Reply